EIZO Corporation
Consolidated Financial Results Explanation Material
In the first quarter of the fiscal year ending March 2027, net sales were 200.3 billion yen, an 18.8% YoY increase, with operating income of 807 million yen, a 4.6 point increase. Segment-wise, Healthcare (HC) contributed the most, and overseas sales are also on an increasing trend. Detailed explanations of future outlook and strategies are provided.
Key Figures
- Net Sales: 200.3 billion yen (YoY +18.8%)
- Operating Income: 807 million yen (4.6 points increase)
- Gross Profit Margin: 34.6% (+1.0pt)
AI要約
Performance Overview
In the first quarter of the fiscal year ending March 2027, consolidated financial results recorded net sales of 200.3 billion yen (an 18.8% YoY increase) and operating income of 807 million yen (a 4.6 point increase). The increase in net sales is driven by healthy overseas markets and expansion across segments, with Healthcare (HC) and V&S making notable contributions. The gross profit margin has also improved, indicating efficient cost management. Graphs and detailed segment analysis are included.
Future Outlook and Strategies
The document also details future performance forecasts and strategic initiatives. Focus is on expanding overseas sales and promoting new businesses to achieve further growth in sales and profits. Growth strategies and investment plans for each segment are clearly outlined, providing essential information for investors. Detailed analysis using graphs and charts is also included.
Tokyo Stock Exchange Prime Market
Company overview · Stock price · Financial data · All IR
